![Prostate Cancer Foundation](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="100%" height="100%"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
![Prostate Cancer Foundation](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="250" height="148"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Session 4: Panel: Where Do Clinical Trials Come From
PCF Young Investigator Forum: October 22, 2021 9:45 AM – 10:45 AM
Moderator:
Atish Choudhury, MD, PhD
Dana Farber Cancer Institute
Panelists:
Maha Hussain, MD
Northwestern University
S. Percy Ivy, MD
Cancer Therapy Evaluation Program (CTEP), National Cancer Institute
Bin Liu, PhD
University of California, San Francisco
Alexander Wyatt, PhD
Vancouver Prostate Centre
Margaret K. Yu, MD
Janssen R & D. LLC.